Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

This study has been terminated.

( the study was terminated because of slow enrollment )

Study NCT00078806 Information provided by Amgen

First Received: March 5, 2004 Last Updated: April 30, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Enbrel
Placebo

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial

Amgen
Immunex Corporation